In addition to this, the company is engaged in providing services for the third party Manufacturers in this domain. The company has emerged as a global Pharmaceutical Company with its clear focus on advancing the treatment of patients who demand critical care. It has gained a reliable name for providing innovative and highly cost-effective medicines to the worldwide hospital marketplace. The compa
ny has about 50 owned as well as registered products, which are made available as franchisee products in bulk quantities. Additionally, it holds third-party manufacturing (As per the demands of the clients) rights in India as well as abroad for offering ready-to-use Allopathic formulations that can be used in new drug applications. What makes our products stand out in comparison to other alternatives available is the fact that these possess favorable attributes to satisfy the unmet medical needs in the Critical Care Hospital Product Market.
